Trajectories of anxiety among breast cancer patients treated with chemotherapy pre- and post-chemotherapy compared to healthy controls: A nationwide multicenter study.
Carly L. Paterson(National Cancer Institute), Michelle C. Janelsins(University of Rochester), Charles Kamen(University of Rochester), Charles E. Heckler(University of Rochester Medicine), Victor Kipnis(National Cancer Institute), K Schmidt(Metro-Minnesota Community Oncology Research Consortium), Jerry W. Mitchell(Seagen (Canada)), Ann M. O’Mara(National Cancer Institute), Mary Ontko(Dayton Clinical Oncology Program)
Cited by 5
Related Papers
Development of the National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
|JNCI Journal of the National Cancer Institute|2014|1.1k
Validity and Reliability of the US National Cancer Institute’s Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
|JAMA Oncology|2015|1k
Comparison of Pharmaceutical, Psychological, and Exercise Treatments for Cancer-Related Fatigue
|JAMA Oncology|2017|913
Prevalence, Demographics, and Psychological Associations of Sleep Disruption in Patients With Cancer: University of Rochester Cancer Center–Community Clinical Oncology Program
|Journal of Clinical Oncology|2009|564
Pooled Results From 5 Validation Studies of Dietary Self-Report Instruments Using Recovery Biomarkers for Energy and Protein Intake
|American Journal of Epidemiology|2014|529